Human papillomavirus, or HPV, has been in the news a lot lately because of the new HPV vaccine, which is intended to prevent cervical cancer resulting from HPV infection when administered to women ages 9 to 26 years. How has the introduction of this vaccine, marketed by Merck under the trade name Gardasil, changed the face of HPV in medicine?
In “How Should We Counsel Women About HPV Testing?” on Medscape, Susan J. Wysocki, RNC, NP, FAANP,
President and CEO, National Association of Nurse Practitioners in Women’s Health, recommends covering the following points when talking with patients about HPV testing and …read more